Biointelect is a strategic planning and commercialisation firm for the biopharmaceutical and medical device sector including commercial, government and not-for-profit organisations.
Our clients include early stage biotech and medtech companies, pharmaceutical companies, universities, research institutes, government and other not-for-profit organisations.
Biointelect helps clients to develop and drive strategy, identify and evaluate new business opportunities and engage the right partners. We advise clients on the spectrum of therapeutic development from start up through to post launch, with an Australian and a Global perspective.
Our view of the life science ecosystem means we are well placed to provide thought leadership on health technology policy issues.
Our international experience is our point of difference.
- Our senior people have operational and launch experience in industry in Europe, the US, and Asia Pacific.
- We have extensive networks in all major markets of clinicians, payers, policy makers, industry experts and HTA experts.
- Our team is diverse in nationality and language skills
- We have access to trusted partners to complement our team where needed with specific technical expertise, language skills, networks, or just feet on the ground.
- Our knowledge is current.
Why choose Biointelect?
We provide a cost effective solution to complement your team’s capabilities.
We work collaboratively with our clients to optimise commercial results.
Our proven track record in new product launches and start-up ventures combined with our extensive international network ensures we have the expertise to help our clients achieve their goals both regionally and globally.
Case studies
Case study 1
Opportunity and market potential for a new allergy treatment in childrenGoal:
- Biotech company aims to develop its first product for novel allergy treatment in children through to clinical proof of concept before partnering with a global pharmaceutical firm and its currently raising capital to support pre-clinical development program
- Assess the opportunity and market potential for this treatment for potential investors
Case study 2
Development of commercialisation business case for NHMRC grant applicationGoal:
- University research group has discovered and patented a novel product to break antibiotic resistance
- To further develop this technology, they are submitting funding application to the NHMRC Development Grant Scheme
Case study 3
Pan-tumour HTA policyGoal:
- Provide advice to Industry sub-committee on PBAC review of pan-tumour issues in immuno-oncology
Case study 4
Industry engagement strategy: data linkageGoal:
- University network of linked data sets needed industry engagement strategy
- Strategic intent was to identify uses of linked data to support therapeutic development
Case study 5
Technical due diligence for an acquisition targetGoal:
- Assess the scientific and commercial value behind a US-based platform technology company
Case study 6
Nanoparticle drug reformation product development strategyGoal:
- Biotech company is reformulating 3 approved oncology drugs (small molecules and biologics) for US and EU market
- Assess the opportunity and market potential for these lead candidates for potential investors
- Generate pitch deck for presentation to investors to include market assessment and revenue projections for key global markets, along with strategic, regulatory, clinical and HEOR considerations
Case study 7
NPP: Reimbursement strategyGoal:
- Australian MNP company needing to develop reimbursement strategy for novel rare cancer therapy
Case study 8
Go to market: Pneumococcal conjugate vaccines (PVC)Goal:
- MNP company wanted to develop Go To Market strategy for a novel pneumococcal conjugate vaccine
- Context focused on evidence gaps to support reimbursement and likely disease burden studies to fill gaps
Why choose Biointelect?
We provide a cost effective solution to complement your team’s capabilities.
We work collaboratively with our clients to optimise commercial results.
Our proven track record in new product launches and start-up ventures combined with our extensive international network ensures we have the expertise to help our clients achieve their goals both regionally and globally.
Our people
The Biointelect management team individually have greater than 20 years’ experience and proven track records in small start-up ventures and multinational corporations. We, therefore, uniquely understand our client’s needs. We have successfully managed business units or companies and navigated complex regulatory, clinical research, quality management, commercial, product launches and business partnering strategies in Australia, Europe and the US.
Our consulting philosophy is to always offer a personalised and adaptable service. We take ownership of our projects seriously and strive for success as if we were part of your team.
